Copyright
©The Author(s) 2021.
World J Stem Cells. May 26, 2021; 13(5): 470-484
Published online May 26, 2021. doi: 10.4252/wjsc.v13.i5.470
Published online May 26, 2021. doi: 10.4252/wjsc.v13.i5.470
n | Mean | SD | Mean rank | χ2 | df | P value | |
Pre-test | 6 | 18.67 | 4.72 | 5.83 | 29.439 | 5 | 0.000 |
Post-test 1 wk | 6 | 16.83 | 6.15 | 5.17 | |||
Post-test 1 mo | 6 | 14.00 | 7.62 | 3.92 | |||
Post-test 2 mo | 6 | 12.17 | 6.94 | 2.92 | |||
Post-test 4 mo | 6 | 10.17 | 6.65 | 2.17 | |||
Post-test 12 mo | 6 | 7.67 | 6.12 | 1.00 |
- Citation: Kabatas S, Civelek E, Savrunlu EC, Kaplan N, Boyalı O, Diren F, Can H, Genç A, Akkoç T, Karaöz E. Feasibility of allogeneic mesenchymal stem cells in pediatric hypoxic-ischemic encephalopathy: Phase I study. World J Stem Cells 2021; 13(5): 470-484
- URL: https://www.wjgnet.com/1948-0210/full/v13/i5/470.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v13.i5.470